Andy Kim Explores Adopting EU Drug Regulation Models in the US

EU Qualified Persons Framework

• 💡 The EU's model of Qualified Persons for drug regulation, which has been in practice for decades, was discussed.
• 🎯 This framework assigns personal responsibility for verifying that imported products meet expected standards.

Existing US Analogues and Novelty

• 🧩 While not entirely novel, the EU model has parallels in the US, such as under the Food Safety Modernization Act (FSMA) for drug importers.
• 🔑 The Sarbanes-Oxley (SOX) bill is cited as another example of a framework where individuals take personal responsibility for what is presented.
• 🛠️ Similar accountability structures exist in other professions, indicating the concept is not entirely new to the US.

Implementation Challenges and Considerations

• ⚖️ Implementing such a framework in the US would necessitate modifying legislation, specifically changes to the Drug and Cosmetic Act by the Health Committee.
• 🌍 The scope of implementation could vary; the EU model applies to domestic manufacturers, whereas a US adaptation might focus on countries with less comparable regulatory systems.
• 💰 The necessity and cost of mandatory batch testing for imported drugs, similar to Europe's approach where products must arrive before testing, were raised as significant considerations.

Reliance on Foreign Drug Manufacturing

• 📈 The US has a massive reliance on foreign drug production, particularly from India, which supplied 61% of solid oral dose products in 2024.
• 🎯 Addressing this reliance through methods like onshoring or alternative quality assurance mechanisms is crucial given the scale of imports.

Benefits of Independent Batch Testing

• ✅ Adopting a model with independent batch testing and verification before drugs are released into the US market could significantly reduce risks associated with substandard imported medications.
• ⚠️ This approach aims to prevent US patients from unknowingly consuming recalled or ineffective drugs, thereby enhancing patient safety.